Drug
Vancomycin (IV)
Vancomycin (IV) is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
2(50%)
Results Posted
200%(2 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_2
1
25%
Ph phase_4
1
25%
Ph phase_1
1
25%
Ph phase_3
1
25%
Phase Distribution
1
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Terminated(1)
Detailed Status
Recruiting2
Terminated1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
Trials by Status
terminated125%
recruiting250%
completed125%
Recent Activity
2 active trials
Showing 4 of 4
recruitingphase_4
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
NCT06637332
recruitingphase_1
Vancomycin Dose Optimization in Obesity
NCT06601257
completedphase_2
Study of Debio 1450 for Bacterial Skin Infections
NCT02426918
terminatedphase_3
Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections
NCT00108433
Clinical Trials (4)
Showing 4 of 4 trials
NCT06637332Phase 4
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
NCT06601257Phase 1
Vancomycin Dose Optimization in Obesity
NCT02426918Phase 2
Study of Debio 1450 for Bacterial Skin Infections
NCT00108433Phase 3
Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4